Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02839460 · ClinicalTrials.gov registry record
A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 30
- Enrollment target
NCT02839460: Completed study, sponsored by University of Florida.
NCT02839460 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02839460 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a single center, prospective biomarker study to evaluate serum levels of TWEAK and expression levels of TWEAK and Fn14 in muscle biopsies from patients with sarcopenia as well as healthy, physically active controls.
Interventions
- PROCEDURE Outpatient Muscle Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-03 |
What the finished NCT02839460 record still lists
NCT02839460 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Outpatient Muscle Biopsy is the first listed.
NCT02839460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02839460 about?
NCT02839460 is a clinical study titled "A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy". This is a single center, prospective biomarker study to evaluate serum levels of TWEAK and expression levels of TWEAK and Fn14 in muscle biopsies from patients with sarcopenia as well as healthy, physically active controls.
What is the current status of trial NCT02839460?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-11. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02839460?
The interventions under investigation include: Outpatient Muscle Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02839460?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia